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Summary: Highly purified human serum glycoproteins were treated with neuraminidase. The exposed subterminal
carbohydrate structures reacted strongly with an anti-galactan precipitin from the haemolymph of Tridacna maxima
which detects terminal, non-reducing ß-D-galactoside residues. This invertebrate precipitin, Tridacnin, may be used
as a marker for nearly two thirds of all asialo serum glycoproteins. A number of different cross-reactions with various
other polysaccharides and galactans subdivides those neuraminidase-treated glycoproteins into several subgroups,
indicating that the uncovered carbohydrate structures are not always completely identical. In this way, together
with the cross-reacting precipitins from plant and invertebrate origin, Tridacnin may be a useful tool for elucidating
and establishing the structure of the carbohydrate part of serum glycoproteins.
Ein neuer Marker fur mit Neuraminidase behandelte Serum-Glykoproteine des Menschen aus der Hämolymphe von
Tridacna maxima (Röding)
Zusammenfassung: Hochgereinigte menschliche Serum-Glykoproteine wurden mit Neuraminidase behandelt. Die dabei
freigelegten subterminalen Kohlenhydratstrukturen reagierten stark mit einem Anti-Galactan Präzipitin aus der
Hämolymphe von Tridacna maxima, welches endständige, nicht-reduzierend gebundene ß-D-Galactosido-Reste erfaßt.
Dieses Präzipitin aus Invertebraten, Tridacnin, kann als Marker für nahezu zwei Drittel aller Asialo-Serum-Glykopro-
teine benutzt werden. Eine ganze Reihe verschiedener Kreuzreaktionen mit einigen anderen Polysacchariden und
Galactanen unterteilt diese Neuraminidase-behandelten Glykoproteine wiederum in mehrere Untergruppen, was
darauf hinweist, daß die freigelegten Kohlenhydratgruppierungen nicht alle vollständig identisch untereinander sind.
In dieser Hinsicht kann Tridacnin, zusammen mit kreuzreagierenden Präzipitinen von Pflanzen und Invertebraten, als
ausgezeichnetes Reagenz benutzt werden, um die Struktur der Kohlenhydratanteile von Serum-Glykoproteinen auf-
zuklären.
Introduction
During the last decade our work has been mainly con-
cerned with the chemical structure and the serological
reactions of the carbohydrate groups from different
cell membrane glycosubstances, which are uncovered
or de novo serologically available after neufaminidase
treatment: -linked N-acetyl-D-gäläctosamine (the so-
calledHelix pornatia (HP)-receptor), /MD-galactosyl-
(l-3)-N-acetyl-Z)-galactosamiiie (the so-called Thomsen-
Friedenreich or TF receptor) and N-acetyl-läctösamiiie
*) This work has been supported by the Deutsche Forschungs^
gemeihschaft.
(the pneumococcus Type XIV cross-reacting receptor).
This work has been summarized in a recent review (1).
Subsequently, identical terminal carbohydrate
structures have been found in soluble glycosubstances like
submaxillary gland mücin (HP) (2), in the anti-freeze
glycoprptein (Tp) (3) and in human serum glycoproteins
(XIV) (4) of the N-acetyl-lactosamine type (5). The fact
that 0-galactoside structures, linked 1-4 (or 1-6? )
glycpsidically to N-acetyl-£)-glucosamine do occur (5) in
most human serum glycoproteins after neuraminidase
treatment prompted us to investigate the reaction of
Tridacnin (6), a potent anti-/3-(l-6 or l-4)-galactoside
precipitin (it was named anti-galactan because of its
reaction with galactan polysaccharides) with neuramini-
dase-treated serum glycoproteins (4).
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The results of our investigations show that Tridacnin
indeed gives a strong precipitin reaction with most of
the neuraminidase-treated serum glycoproteins and may
be useful as a novel tool in research or clinical diagnosis
(polyagglutinability).
Materials and Methods
Purified serum glycoproteins: Preparations from the Behring-
werke Marburg.
Tridacnin: A purified sample from the haemolymph of Tridacna
maxima was used (6). IgA mouse myeloma protein from ascites
fluid was kindly supplied by Dr. Michael Potter (7).
Galactans: Galactans of various origins were used and have also
been described and listed in previous papers of this series (7,8).
Agar-gel electrophoresis and gel diffusion were performed in the
usual way, as mentioned in earlier papers (6, 7, 8, 9).
Neuraminidase-treatment of glycoprotein samples: Purified
glycoproteins were dissolved in Neuraminidase (Behringwerke)
to make up a 5% solution. Incubation time at 37 °C was 1.5 h.
The solution was used in this way for agar-gel diffusion or gel
electrophoresis tests.
In a typical experiment, 5 mg of the glycoprotein was dissolved
in 0.1 ml neuraminidase, corresponding to 50 units of the
enzyme.
Results
Agar-gel diffusion tests with neuraminidase-treated (= N)
serum glycoproteins and Tridacnin
The results of a first experiment can be seen in figure 1.
Note some "non-complete identity" reaction of cholin-
esterase. Several commercial bovine cell cholinesterases
did not react after neuraminidase treatment. Horse serum
cholinesterase did, however.
Cross-reactions between serum glycoproteins (N) and
galactans
The picture of this experiment is shown in figure 2. Again,
cholinesterase (N) does not give a complete identity line
with the Tridacnin-pqsitive polysaccharide from pneumo-
coccus.
Further cross-reactions with other galactans are shown in
figure 3. The fusion between galactans and serum glyco-
proteins is not always complete (see well 2).
Another example of these cross-reacting fusion lines
between serum glycoproteins (N) and galactans is given
Fig. 1. Agar gel diffusion tests.
Centre Tridacnin
1 = Cholinesterase (N)
2 = Secretory piece IgA (N)
3 = Lactoferrin (N)
4 =? 8S-a3-glycoprotein (N)
5 = 02-glycoprotein I (N)
6 = Haemopexin (N)
Fig. 2. Agar gel diffusion tests.
Centre Tridacnin
1 = Cholinesterase (N)
2,4,6 = Pneumococcus Type XIV
polysaccharide
3 = Lactoferrin (N)
5 = Secretory piece (N)
Fig. 3. Agar gel diffusion tests.
Centre Tridacnin
1 = Cholinesterase (N)
2 = Arabinogalactan (larch)
3 = 02-glycoprotein I (N)
4 = Pneumogalactan (bovine)
5 = Secretory piece (N)
6 = Helix pomatia galactan
Fig. 4. Agar gel diffusion tests.
Centre Tridacnin
1 = Haemopexin (N)
2 = Arabinogalactan (larch)
3 = Lactoferrin (N)
4 = Pneumogalactan (bovine)
5 = a2-macroglobulin (N)
6 = Helix pomatia galactan
Fig. 5. Agar gel diffusion tests.
Centre Tridacnin
1 = Haptoglobin (N)
2 = Arabinogalactan (larch)
3 = 8S-a3-glycoprotein (N)
4 = Fneumogalactan (bovine)
5 = Cholinesterase (N)
6 = Helix pomatia galactan
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in figure 4. Here the lines of Haemopexin (N) and Helix
pomatia galactan do not fuse completely.
Other fusion lines are demonstrated in figure 5. Here
again, Tridacnin precipitates with several galactans and
glycoproteins (N), showing in most cases a complete
identity reaction, in some, however, not. In these cases
slight differences in receptor area must be present.
All these results are summarized in table 1 and 2. Table 1
gives the carbohydrate composition of the glycoproteins
which are very strongly precipitated after neuraminidase
treatment by Tridacnin. Those serum glycoproteins
which only react weakly after neuraminidase treatment
with Tridacnin, and those which do not precipitate in
agar-gel diffusion are listed in table 2. Table 3 summarizes
the different cross-reactions with various galactans. As
can be deduced from the Table, six groups can be
distinguished. Group I also includes a seminal plasma
Tab. 1. Serum glycoproteins, which precipitate strongly with
Tridacnin after they have been treated with neuramini-
dase. (Analysis according to Heide & Schwick (10)).




glycoprotein, on which we will report in another context
(with W. P. Herrmann, unpublished results). The nature of
these different cross-reactions is still unknown.
In this connection, it is interesting to note that IgA from
human colostrum gives two Tridacnin precipitation lines
before treatment with neuraminidase, and only one after-
wards. However, genuine IgA reacts in both cases much
more weakly than the secretory piece in isolated form.
IgA mouse myeloma protein in purified form (7) does
not react with Tridacnin after it has been treated with
neuraminidase. This myeloma protein is a potent anti-
galactan itself.
Agar-gel electrophoretic analysis of serum glycoproteins
(N) with Tridacnin
The neuraminidase-treated serum glycoproteins were
submitted to agar-gel electrophoresis ("immune"-electro-
phoresis) and made visible by their precipitin reaction
with Tridacnin (trough). The results are given in figures
6, 7 and 8. Before neuraminidase-treatment, there was
no visible reaction between Tridacnin and any of these
serum glycoproteins. Reactions with other antigalactans
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Tab. 2. Serum glycoproteins, which react weakly or not at all
with Tridacnin after they had been treated with neura-
minidase.
Tab. 3. Identity reactions, obtained by precipitation (Ouchter·
tony-technique), between Tridacnin and some poly-















+ = identity reaction
—= non-identity reaction
Precipitin reaction with Tridacnin of serum glycoproteiris
after neuraminidase treatment
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Fig. 6. Agar gel electrophoresis ("Immune" electrophoresis).
Troughs: Tridacnin
Upper well: Cholinesterase (N)
Middle well: Secretory piece (N)
Lower well: Lactoferrin (N)
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Fig. 7. Agar gel electrophoresis ("Immune" electrophoresis).
Troughs: Tridacnin
Upper well: a2-macroglobulin (N)
Middle well: SS-aa-glycoprotein (N)
Lower well: Peptone from pig stomach
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Fig. 8. Agar gel electrophoresis ("Immune" electrophoresis).
Troughs: Tridacnin
Upper well: Haemopexin (N)
Middle well: fo-glycoprotein I (N)
Lower well: Haptoglobih (N)
Discussion
Tridacnin is a substance in the haemolymph of the
elongate bivalve.clam Tridacna maxima ((R ding) (8))
which agglutinates erythrocytes and other cells. In
addition, it is a strongly precipitating anti-galactan
(6, 7). Its precipitating and agglutinating properties
have been reviewed recently in a monograph (11). It
has a molecular weight of about 300 000-500 000
Dalton and can be split by reductive cleavage using
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mercaptoethanol and subsequent alkylation into sub-
units of 44 000 and 22 000 Dalton. The acid substance
migrating toward the anode can be precipitated by
basic polymers (lysozyme also) and is easily destroyed
by certain proteases, for instance polymer-bound
pronase (6, 9, 11).
Tridacnin agglutinates red cells of different species,
lymphocytes, thrombocytes, tumour cells and spermato-
zoa (11). In addition, it precipitates preferably with
galactans of different origin, having terminal non
reducing j3-(l-6)-digalactobiose structures, with the
pneumococcus Type XIV polysaccharide (8) and with
a lipopolysaccharide from Salmonella Perth (unpublished
results with 0. Lüderitz).
Tridacnin-reactive material from cell membranes in the
form of a glycoprotein has so far only been isolated
from bovine red cells (8). Peptone from pig stomach (9),
a human seminal plasma glycoprotein and secreted
blood group glycoproteins are precipitated directly,
without any treatment. Of the galactans, the mite
galactan is of particular importance, as it represents
the house dust mite allergen (12). The reactions of
Tridacnin with various glycosubstances are summarized
in Table 4.
The reaction with the neuraminidase-treated serum
glycoproteins may be due to the terminal ]3-(l-4)-
galactosido structures (5). However, not all react and
some, for instance fetuin, for which only this terminal
structure has been established, precipitate only weakly.
Tab. 4. Glycosubstances which are precipitated by Tridacnin
(modified from Uhlenbruck et al. (10)).
I. Glycoproteins
1. genuine: 4. Membrane-
Peptone from porcine stomach integrated
Seminalplasma glycoprotein glycoproteins
Human secreted blood group substances
2. After partial acid hydrolysis:
Bovine red cell mucoid
Secreted blood group glycoproteins
3. After neuraminidase-treatment:






1. Galactans sensu strictu
a) Snail galactans
b) Galactans from plants and algae
c) Pneumogalactan (bovine)
d) Mite galactan (house dust allergen)
and other microbial galactans
2. Cross-reacting polysaccharides from bacteria:
a) Lipopolysaccharides (Salmonella Perth)
b) Pneumococcus Type XIV polysaccharide
As a hypothesis, we therefore favour the view that in
the strongly reacting glycoproteins (N) )3-(l-6)-galactoside
structures may be present too. However, further experi-
ments in this direction must clarify the exact chemical
structure of the Tridacnin receptor in various neura-
minidase-treated serum glycoproteins. This also holds
for the different identity and partial identity reactions
with certain galactans.
Nevertheless, as a special marker for neuramimc-acid-
free serum glycoproteins, Tridacnin may be most useful.
In cases of bacterially caused polyagglutinability, not
only the red cells (TF transformation) but also the serum
glycoproteins are altered by the bacterial neuraminidase
(13). Also of importance is the reaction with the secretory
piece, as it may play a role in colon carcinoma. In addi-
tion, the fate of serum asialoglycoproteins may be
studied. In comparative experiments we found that
Tridacnin reacts and precipitates very much better than
the anti-N-acetyl-lactosamine-specific anti-pnewno-
coccus Type XIV cross-reacting antisemm from horse
(14) hitherto used in blood group research, and also
with human blood group substances, especially after
partial acid hydrolysis.
But even in this case, the reactions are not identical
and comparable with each other (see fig. 9); as with
pneumococcus Type XIV polysaccharide (middle),
Tridacnin and the horse antiserum do not show identical
reactions. This again underlines the difficulty of inter-
preting the numerous cross-reactions of Tridacnin in
immunochemical terms. However, the materials listed
in this paper represent a broad spectrum of glyco-
substances, which may help to elucidate this mechanism.
In this connection it is worth mentioning that lacto-N-
neotetraosyl-ceramide strongly reacts with Tridacnin
(unpublished results with Dr. P. Hanfland, Bonn), a
fact which supports the additional anti-N-acetyl-lactos-
arnine specificity of this precipitin. On the other hand,
quite a number of (jS)-galactoside-specific lectins, for








Fig. 9. Agar gel diffusion tests.
Centre Pneumococcus Type XIV polysaccharide.
1.3.5 = Tridacnin
2.4.6 * Pneumococcus Type XIV antiserum from horse
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täte with a characteristic collection of these neuramini-
dase-treated glycoproteins too (with a2-macroglobulin,
inter-a-trypsin inhibitor, acid aj-glycoprotein, uromucoid,
j^-antichymotrypsin, prothrombin and others) (un-
published results with Dr. V. Horejsi, Prague).
All these findings indicate that different precipitin
reactions with different lectins may make a new, subtile
classification of (serum) asialoglycoproteins possible
on account of slightly differing carbohydrate units
and their special sterical arrangement.
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